These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10971124)

  • 1. Human T lymphotropic virus I in Indonesia. Very low seroprevalence in the Jakarta area: antibodies in healthy blood donors and in various nonhematological diseases.
    Tanggo Y; Gultom SP; Simanjuntak T; Sibuea WH; Matsuzaki H; Yamaguchi K
    Intervirology; 2000; 43(2):77-9. PubMed ID: 10971124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
    Durojaiye I; Akinbami A; Dosunmu A; Ajibola S; Adediran A; Uche E; Oshinaike O; Odesanya M; Dada A; Okunoye O
    Pan Afr Med J; 2014; 17():301. PubMed ID: 25328597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
    Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
    Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
    Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of human T-lymphotropic virus type 1 in Papua New Guinea and Irian Jaya measured using different western blot criteria.
    Takao S; Ishida T; Bhatia KK; Saha N; Soemantri A; Kayame OW
    J Clin Virol; 2000 Apr; 16(2):129-33. PubMed ID: 10720817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
    Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
    J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK; Bhatti FA; Salamat N
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
    Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
    Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell lymphotropic virus type 1 in Zimbabwe.
    Houston S; Thornton C; Emmanuel J; Latif A
    Trans R Soc Trop Med Hyg; 1994; 88(2):170-2. PubMed ID: 8036662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against human T-cell lymphotropic viruses in subjects at high risk for HIV in Monterrey].
    Flores-Castañeda MS; Salinas-Carmona MC; Leal-González C; Yáñez-Rodríguez A; Trejo-Avila LM
    Rev Invest Clin; 1992; 44(1):37-41. PubMed ID: 1523348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
    Mizokami T; Okamura K; Ikenoue H; Sato K; Kuroda T; Maeda Y; Fujishima M
    Thyroid; 1994; 4(4):415-9. PubMed ID: 7711504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.